Literature DB >> 21744989

Expression of the nonclassical HLA class I and MICA/B molecules in human hepatocellular carcinoma.

A Chen1, Y Shen, M Xia, L Xu, N Pan, Y Yin, F Miao, C Shen, W Xie, J Zhang.   

Abstract

HLA-G and HLA-E are nonclassical human MHC class I molecules, which promote tolerance to NK cytotoxicity. MICA and MICB are known to enhance the functions of NK and T cells. However, the expression of these molecules has never been investigated in liver cancer. Using RT-PCR and western blot, we aimed to identify the expression of HLA-G, HLA-E, MICA and MICB in a panel of 41 tissues dissecting from liver cancer patients in China. HLA-G mRNA was expressed in 8 of 41 Human Hepatocellular Carcinoma (HCC) specimens and in 1 adjacent normal hepatocellular tissue. The expression of HLA-G protein was found in 7 of the 8 HLA-G mRNA-positive HCC tissues. HLA-E mRNA was up-regulated in 56% HCC specimens but the expression of HLA-E protein was only upregulated in 29% HCC tissues in comparison with their adjacent normal counterpart. MICA and MICB mRNA was decreased in 5% and 8% HCC specimens, while the expression of their proteins decreased in 21% and 24% HCC tissues. These results suggested that the expressions of HLA-G, HLA-E, MICA and MICB were differently up-regulated in HCC tissues. Furthermore, HLA-E and MICA/B genes showed obviously distinctive expression pattern at transcription and translation level.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744989     DOI: 10.4149/neo_2011_05_371

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  9 in total

1.  MHC-E-Restricted CD8+ T Cells Target Hepatitis B Virus-Infected Human Hepatocytes.

Authors:  Benjamin J Burwitz; Patrick K Hashiguchi; Mandana Mansouri; Christine Meyer; Roxanne M Gilbride; Sreya Biswas; Jennie L Womack; Jason S Reed; Helen L Wu; Michael K Axthelm; Scott G Hansen; Louis J Picker; Klaus Früh; Jonah B Sacha
Journal:  J Immunol       Date:  2020-03-11       Impact factor: 5.422

Review 2.  Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches.

Authors:  Min Yu; Zonghai Li
Journal:  Front Med       Date:  2017-08-05       Impact factor: 4.592

3.  Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection.

Authors:  Qunying Han; Na Li; Qianqian Zhu; Zhu Li; Guoyu Zhang; Jinghong Chen; Yi Lv; Yawen Wang; Zhengwen Liu; Chunqiu Hao
Journal:  Clin Exp Med       Date:  2012-09-25       Impact factor: 3.984

4.  Down-regulation of PR/SET domain 10 underlies natural killer cell dysfunction in hepatocellular carcinoma.

Authors:  Jiantao Han; Chao Ke; Bin Jiang; Hongjian Zhou; Hanbin Xu; Xingwang Xie
Journal:  Clin Exp Immunol       Date:  2021-10-10       Impact factor: 4.330

5.  Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.

Authors:  Hongguang Li; Fangfeng Liu; Huaqiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jinhua Hu
Journal:  Med Sci Monit       Date:  2016-02-19

Review 6.  Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.

Authors:  Pil Soo Sung; Jeong Won Jang
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

7.  Diagnostic and prognostic biomarkers of Human Leukocyte Antigen complex for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Xiang-Kun Wang; Xi-Wen Liao; Cheng-Kun Yang; Ting-Dong Yu; Zheng-Qian Liu; Yi-Zhen Gong; Ke-Tuan Huang; Xian-Min Zeng; Chuang-Ye Han; Guang-Zhi Zhu; Wei Qin; Tao Peng
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

Review 8.  Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Carly J Amato-Menker; Hajar El Hilali; Senthamil R Selvan; Edward J Filippone
Journal:  Antibodies (Basel)       Date:  2022-09-08

Review 9.  Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells.

Authors:  Michela Anna Polidoro; Joanna Mikulak; Valentina Cazzetta; Ana Lleo; Domenico Mavilio; Guido Torzilli; Matteo Donadon
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.